NGM entered into a clinical trial collaboration and supply agreement with Merck to evaluate the potential of NGM707 in combination with KEYTRUDA for the treatment of patients with advanced or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback